Robert Ballard, MD
Sleep Medicine · Littleton, CONPI 1255424347
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.0% of the total across 169 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 17.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,377 and has fallen 91.0% since, to $124 in 2025.
Across 169 payments — averaging $17.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Harmony Biosciences LLC$501
- AstraZeneca$469
- Boehringer Ingelheim$449
- GSK$334
- Grifols USA, LLC$212
- United Therapeutics Corporation$107
- plus $860 from 21 others
What the payments were for
- Food & beverage$2,78595%
- Education$1455%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Harmony Biosciences LLC | 20 | $501 |
| AstraZeneca(2 entities) | 27 | $469 |
| Boehringer Ingelheim | 23 | $449 |
| GSK | 25 | $334 |
| Grifols USA, LLC | 20 | $212 |
| United Therapeutics Corporation | 6 | $107 |
| Sunovion Pharmaceuticals Inc. | 5 | $102 |
| Mylan Specialty L.p. | 5 | $82 |
| Jazz Pharmaceuticals Inc. | 4 | $78 |
| Optinose US, Inc. | 4 | $70 |
| Shire North American Group Inc | 3 | $60 |
| Novartis | 3 | $59 |
| Sanofi | 3 | $59 |
| Philips North America LLC | 3 | $48 |
| Insmed, Inc. | 2 | $38 |
| Portola Pharmaceuticals, LLC | 2 | $33 |
| Circassia Inc. | 2 | $32 |
| Merck | 2 | $30 |
| Johnson & Johnson | 2 | $29 |
| Resmed Corp | 1 | $25 |
| Advanced Respiratory, Inc | 1 | $21 |
| ZOLL Respicardia, Inc. | 1 | $20 |
| Nevro Corp. | 1 | $20 |
| Baxter Healthcare | 1 | $17 |
| Gilead | 1 | $13 |
| Biogen | 1 | $12 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
How this compares
$2,930 in reported general payments places this provider in the 80th percentile of 35 sleep medicine providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 63 | $48,585 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 21 | $19,158 |
| Spiriva RespimatTiotropium Bromide | 11 | $14,690 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 39 | $1,066 |
| Gabapentin | 22 | $444 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 16 | $376 |
| Clonazepam | 13 | $133 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Anoro Ellipta | $334 | $67,74284 claims |
| Boehringer IngelheimSpiriva Respimat | $449 | $14,69011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 35 sleep medicine providers in Colorado.
Other sleep medicine in Littleton
- Stephen DuntleyAurora$17K
- Anthony BarberBoulder$8K
- Sheila TsaiDenver$7K
- George JuetersonkeColorado Springs$7K
- Keith SwartzDenver$5K
- Katherine GreenAurora$4K
- James MetkusLakewood$2K
- Siavash PanahGreeley$2K
- Ari WalterBoulder$1K
- Bogdan StrambuParker$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.